Update: Moderna Shares Tumble After 2025 Revenue Guidance Cut-March 2024-www.financetom.com

Update: Moderna Shares Tumble After 2025 Revenue Guidance Cut

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Update: Moderna Shares Tumble After 2025 Revenue Guidance Cut

Jan 13, 2025 9:19 AM

11:49 AM EST, 01/13/2025 (MT Newswires) -- (Updates with the recent stock move in the headline and the first paragraph.)

Moderna ( MRNA ) shares were down nearly 22% in recent Monday trading after the company said it now expects 2025 revenue to be between $1.5 billion and $2.5 billion, down from the previous range of $2.5 billion to $3.5 billion.

Analysts surveyed by FactSet expect $2.92 billion.

The drugmaker said it is accelerating its cost efficiency and prioritization programs, with projected cash cost reductions of $1 billion in 2025.

The company said it expects to end 2025 with cash and investments of about $6 billion.

Moderna ( MRNA ) will report its Q4 financial results on Feb. 14.

Price: 33.12, Change: -9.14, Percent Change: -21.62

Previous page： Carnival Prices $1.18 Billion 4.125% Senior Unsecured Notes Offering Next page： ArriVent BioPharma Plans $75 Million Public Offering

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Carnival Prices $1.18 Billion 4.125% Senior Unsecured Notes Offering

Jul 1, 2025

04:22 PM EDT, 07/01/2025 (MT Newswires) -- Carnival (CCL) said Tuesday it has priced a private offering of $1 billion euros ($1.18 billion) of 4.125% senior unsecured notes due 2031. Proceeds will be used to fully repay borrowings under a first-priority senior secured term loan facility maturing in 2027 and to repay part of borrowings under a first-priority senior secured...

ArriVent BioPharma Plans $75 Million Public Offering

Jul 1, 2025

04:24 PM EDT, 07/01/2025 (MT Newswires) -- ArriVent BioPharma ( AVBP ) said late Tuesday it plans a $75 million public offering of common shares and pre-funded warrants. The company said it will offer underwriters a 30-day overallotment option to buy up to an additional 15% of the total offering size. ArriVent will use the net proceeds to advance activities...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Constellation Brands Q1 Adjusted Earnings, Revenue Fall; Maintains Fiscal 2026 Comparable EPS Guidance

Jul 1, 2025

04:24 PM EDT, 07/01/2025 (MT Newswires) -- Constellation Brands ( STZ ) reported fiscal Q1 adjusted earnings late Tuesday of $3.22 per diluted share, down from $3.57 a year earlier. Analysts surveyed by FactSet expected $3.31. Net sales for the quarter ended May 31 were $2.52 billion, down from $2.66 billion a year earlier. Analysts polled by FactSet expected $2.55...